Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Personalized risk-based screening for diabetic retinopathy: A multivariate approach versus the use of stratification rules.

García-Fiñana M, Hughes DM, Cheyne CP, Broadbent DM, Wang A, Komárek A, Stratton IM, Mobayen-Rahni M, Alshukri A, Vora JP, Harding SP.

Diabetes Obes Metab. 2019 Mar;21(3):560-568. doi: 10.1111/dom.13552. Epub 2018 Oct 30.

2.
3.

Effect of oral phosphate and alendronate on bone mineral density when given as adjunctive therapy to growth hormone replacement in adult growth hormone deficiency.

White HD, Ahmad AM, Durham BH, Joshi AA, Fraser WD, Vora JP.

J Clin Endocrinol Metab. 2011 Mar;96(3):726-36. doi: 10.1210/jc.2010-1929. Epub 2011 Jan 20.

PMID:
21252245
4.

Correlation of serum-adjusted calcium with ionized calcium over a 24-h period in patients with adult growth hormone deficiency before and after growth hormone replacement.

White HD, Joshi AA, Ahmad AM, Durham BH, Vora JP, Fraser WD.

Ann Clin Biochem. 2010 May;47(Pt 3):212-6. doi: 10.1258/acb.2010.009178. Epub 2010 Apr 14.

PMID:
20392749
5.

Endocrine evaluation of pituitary tumours.

Saunders S, Vora JP.

Br J Neurosurg. 2008 Aug;22(4):602-8. doi: 10.1080/02688690802385974.

PMID:
18803082
6.

Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.

Joseph F, Ahmad AM, Ul-Haq M, Durham BH, Whittingham P, Fraser WD, Vora JP.

J Bone Miner Res. 2008 May;23(5):721-9.

7.

PTH circadian rhythm and PTH target-organ sensitivity is altered in patients with adult growth hormone deficiency with low BMD.

White HD, Ahmad AM, Durham BH, Peter R, Prabhakar VK, Corlett P, Vora JP, Fraser WD.

J Bone Miner Res. 2007 Nov;22(11):1798-807.

8.

The circadian rhythm of osteoprotegerin and its association with parathyroid hormone secretion.

Joseph F, Chan BY, Durham BH, Ahmad AM, Vinjamuri S, Gallagher JA, Vora JP, Fraser WD.

J Clin Endocrinol Metab. 2007 Aug;92(8):3230-8. Epub 2007 Jun 5.

PMID:
17550963
9.

Effect of active acromegaly and its treatment on parathyroid circadian rhythmicity and parathyroid target-organ sensitivity.

White HD, Ahmad AM, Durham BH, Chandran S, Patwala A, Fraser WD, Vora JP.

J Clin Endocrinol Metab. 2006 Mar;91(3):913-9. Epub 2005 Dec 13.

PMID:
16352693
10.

Growth hormone replacement is important for the restoration of parathyroid hormone sensitivity and improvement in bone metabolism in older adult growth hormone-deficient patients.

White HD, Ahmad AM, Durham BH, Patwala A, Whittingham P, Fraser WD, Vora JP.

J Clin Endocrinol Metab. 2005 Jun;90(6):3371-80. Epub 2005 Mar 1.

PMID:
15741264
11.

The physiology of the circadian rhythm of parathyroid hormone and its potential as a treatment for osteoporosis.

Fraser WD, Ahmad AM, Vora JP.

Curr Opin Nephrol Hypertens. 2004 Jul;13(4):437-44. Review.

PMID:
15199294
12.
13.

Parathyroid responsiveness to hypocalcemic and hypercalcemic stimuli in adult growth hormone deficiency after growth hormone replacement.

Ahmad AM, Hopkins MT, Thomas J, Durham BH, Fraser WD, Vora JP.

Am J Physiol Endocrinol Metab. 2004 Jun;286(6):E986-93.

14.

Gender variation in PTH sensitivity and rhythmicity following growth hormone replacement in adult growth hormone-deficient patients.

White HD, Ahmad AM, Syed AA, Clewes A, Peter R, Vora JP, Fraser WD.

Clin Endocrinol (Oxf). 2004 Apr;60(4):516-26. Erratum in: Clin Endocrinol (Oxf). 2004 Jul;61(1):160-1.

PMID:
15049968
15.

Ambulatory photographic screening for diabetic retinopathy in nursing homes.

Anderson S, Broadbent DM, Swain JY, Vora JP, Harding SP.

Eye (Lond). 2003 Aug;17(6):711-6.

PMID:
12928682
16.

Incidence of sight-threatening retinopathy in Type 1 diabetes in a systematic screening programme.

Younis N, Broadbent DM, Harding SP, Vora JP.

Diabet Med. 2003 Sep;20(9):758-65.

PMID:
12925058
17.

Effects of growth hormone replacement on parathyroid hormone sensitivity and bone mineral metabolism.

Ahmad AM, Thomas J, Clewes A, Hopkins MT, Guzder R, Ibrahim H, Durham BH, Vora JP, Fraser WD.

J Clin Endocrinol Metab. 2003 Jun;88(6):2860-8.

PMID:
12788900
18.

Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men.

Diver MJ, Imtiaz KE, Ahmad AM, Vora JP, Fraser WD.

Clin Endocrinol (Oxf). 2003 Jun;58(6):710-7.

PMID:
12780747
19.

Gender variation in leptin circadian rhythm and pulsatility in adult growth hormone deficiency: effects of growth hormone replacement.

White HD, Ahmad AM, Guzder R, Wallace AM, Fraser WD, Vora JP.

Clin Endocrinol (Oxf). 2003 Apr;58(4):482-8.

PMID:
12641632
20.

Parathyroid hormone secretory pattern, circulating activity, and effect on bone turnover in adult growth hormone deficiency.

Ahmad AM, Hopkins MT, Fraser WD, Ooi CG, Durham BH, Vora JP.

Bone. 2003 Feb;32(2):170-9.

PMID:
12633789
21.

Effects of adult growth hormone deficiency and growth hormone replacement on circadian rhythmicity.

White HD, Ahmad AM, Vora JP.

Minerva Endocrinol. 2003 Mar;28(1):13-25. Review.

PMID:
12621360
22.

Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study.

Younis N, Broadbent DM, Vora JP, Harding SP; Liverpool Diabetic Eye Study.

Lancet. 2003 Jan 18;361(9353):195-200.

PMID:
12547541
23.

Current status of screening for diabetic retinopathy in the UK.

Younis N, Broadbent DM, James M, Harding SP, Vora JP.

Diabet Med. 2002 Jul;19 Suppl 4:44-9.

PMID:
12121337
24.

Effects of GH replacement on 24-h ambulatory blood pressure and its circadian rhythm in adult GH deficiency.

Ahmad AM, Hopkins MT, Weston PJ, Fraser WD, Vora JP.

Clin Endocrinol (Oxf). 2002 Apr;56(4):431-7.

PMID:
11966735
25.

The role of somatostatin receptor scintigraphy in the management of pituitary tumours.

Moulik PK, Varma TR, Vora JP, Vinjamuri S.

Nucl Med Commun. 2002 Feb;23(2):117-20. Review.

PMID:
11891464
26.

Circadian and ultradian rhythm and leptin pulsatility in adult GH deficiency: effects of GH replacement.

Ahmad AM, Guzder R, Wallace AM, Thomas J, Fraser WD, Vora JP.

J Clin Endocrinol Metab. 2001 Aug;86(8):3499-506.

PMID:
11502770
27.

Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement.

Ahmad AM, Hopkins MT, Thomas J, Ibrahim H, Fraser WD, Vora JP.

Clin Endocrinol (Oxf). 2001 Jun;54(6):709-17.

PMID:
11422104
28.

Beta blocker prescribing differences in patients with and without diabetes following a first myocardial infarction.

Younis N, Burnham P, Patwala A, Weston PJ, Vora JP.

Diabet Med. 2001 Feb;18(2):159-61.

PMID:
11251682
29.

Responding to the challenge of diabetic nephropathy: the historic evolution of detection, prevention and management.

Vora JP, Ibrahim HA, Bakris GL.

J Hum Hypertens. 2000 Oct-Nov;14(10-11):667-85. Review.

PMID:
11095158
30.

Diabetic nephropathy.

Ibrahim HA, Vora JP.

Baillieres Best Pract Res Clin Endocrinol Metab. 1999 Jul;13(2):239-64. Review.

PMID:
10761865
31.

Prevalence of diabetic eye disease in an inner city population: the Liverpool Diabetic Eye Study.

Broadbent DM, Scott JA, Vora JP, Harding SP.

Eye (Lond). 1999 Apr;13 ( Pt 2):160-5.

PMID:
10450374
32.

Dancing eyes-dancing feet.

Imtiaz KE, Vora JP.

Lancet. 1999 Jul 31;354(9176):390. No abstract available.

PMID:
10437869
33.
34.

Pregnant, vomiting, and going blind.

Tesfaye S, Achari V, Yang YC, Harding S, Bowden A, Vora JP.

Lancet. 1998 Nov 14;352(9140):1594. No abstract available.

PMID:
9843106
35.

Development and progression of microalbuminuria in a clinic sample of patients with insulin dependent diabetes mellitus.

Jones CA, Leese GP, Kerr S, Bestwick K, Isherwood DI, Vora JP, Hughes DA, Smith C.

Arch Dis Child. 1998 Jun;78(6):518-23.

36.

Atrial natriuretic peptide in type 2 diabetes mellitus: response to a physiological mixed meal and relationship to renal function.

Chattington PD, Anderson JV, Rees LH, Leese GP, Peters JR, Vora JP.

Diabet Med. 1998 May;15(5):375-9.

PMID:
9609358
37.

Gonadal status is an important determinant of bone density in acromegaly.

Lesse GP, Fraser WD, Farquharson R, Hipkin L, Vora JP.

Clin Endocrinol (Oxf). 1998 Jan;48(1):59-65.

PMID:
9509069
38.

Diagnostic difficulties in periodic Cushing's syndrome.

Walker AB, Leese GP, Vora JP.

Postgrad Med J. 1997 Jul;73(861):426-8.

39.

Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.

Vora JP, Oyama TT, Thompson MM, Anderson S.

Diabetes. 1997 Jan;46(1):107-12.

PMID:
8971089
40.

Detection of sight-threatening diabetic eye disease.

Leese GP, Broadbent DM, Harding SP, Vora JP.

Diabet Med. 1996 Oct;13(10):850-3. Review.

PMID:
8911777
41.

Enhanced renal sensitivity to angiotensin actions in diabetes mellitus in the rat.

Kennefick TM, Oyama TT, Thompson MM, Vora JP, Anderson S.

Am J Physiol. 1996 Sep;271(3 Pt 2):F595-602.

PMID:
8853421
42.

The diabetic patient with hypertension.

Leese GP, Savage MW, Chattington PD, Vora JP.

Postgrad Med J. 1996 May;72(847):263-8. Review.

43.

The management of hypertension in diabetes: with special reference to diabetic kidney disease.

Leese GP, Vora JP.

Diabet Med. 1996 May;13(5):401-10. Review.

PMID:
8737020
44.
45.

Evolution of metabolic and renal changes in the ZDF/Drt-fa rat model of type II diabetes.

Vora JP, Zimsen SM, Houghton DC, Anderson S.

J Am Soc Nephrol. 1996 Jan;7(1):113-7.

46.

Diabetic renal disease: microalbuminuria, implications and intervention.

Savage MW, Leese GP, Vora JP.

Nutrition. 1995 Nov-Dec;11(6):761-4. Review.

PMID:
8719137
47.

Therapeutic options in diabetic renal disease and hypertension.

Savage MW, Leese GP, Chattington P, Vora JP.

Br J Hosp Med. 1995 Nov 1-14;54(9):429-34. Review.

PMID:
8564177
48.

Current concepts of renal hemodynamics in diabetes.

Anderson S, Vora JP.

J Diabetes Complications. 1995 Oct-Dec;9(4):304-7. Review.

PMID:
8573753
49.

Clinical interventions in diabetic renal disease.

Leese GP, Vora JP.

Curr Opin Nephrol Hypertens. 1995 Mar;4(2):139-45. Review.

PMID:
7600044
50.

Down-regulation of the intrarenal renin-angiotensin system in the aging rat.

Jung FF, Kennefick TM, Ingelfinger JR, Vora JP, Anderson S.

J Am Soc Nephrol. 1995 Feb;5(8):1573-80.

Supplemental Content

Support Center